Lakeland, FL -- (SBWIRE) -- 08/20/2013 -- Penny Stock Divas is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our best penny stock picks. Here Penny Stock Divas brings a special report on: Bayer AG (ADR) (OTCMKTS:BAYRY), Exide Technologies (OTCMKTS:XIDEQ), Brainstorm Cell Therapeutics Inc (OTCBB:BCLI), Kubota Corp (ADR) (OTCMKTS:KUBTY)
Bayer AG (ADR) (OTCMKTS:BAYRY) remained a bull for the day as it reported the upward momentum of 0.55% and closed at $116.27 after gaining total volume of 16,780.00 shares. Its introductory price for the day was $116.08. So far, the company’s stock is up 7.53% in the three months period. In the last 6 months of trade it reported a gain of 20.9%.Bayer AG is a German management holding company with core competencies in the field of health care, nutrition and high-tech materials. It's business operations are organized into three subgroups: HealthCare, involved in the research, development and manufacture of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control.
For How Long BAYRY will Fight for Profitability? Read This Trend Analysis report
Exide Technologies (OTCMKTS:XIDEQ) reported the gain of 2.65% and closed at $ 0.190 with the total traded volume of 507,203.00 shares. The stock's opening price was $ 0.19. The company has a total market capitalization of $ 15.12 million.
The 52-week price range of the stock remained $0.11 - $3.75, while during last trade its minimum price was $0.17 and it gained its highest price of $0.19. Company's last 5 days shows an uptrend turn with an a decline of 5.5%.Exide Technologies (Exide) is engaged in stored electrical energy solutions, and is a manufacturer and supplier of lead-acid batteries for transportation and industrial applications in the worldwide. Exide operates in four business segments: Transportation Americas, Transportation Europe and ROW, Industrial Energy Americas, and Industrial Energy Europe and ROW.
For How Long XIDEQ Gloss will Attract Investors? Find out via this report
Brainstorm Cell Therapeutics Inc (OTCBB:BCLI) ended its day with the declining stream with the plunge of -3.16% and closed at the price of $0.184 after opening at $0.20. Stock traded during its last trading session with the total volume of 548,389.00 shares, as compared to its average volume of 525,252.00 shares.
During the previous session, the company’s minimum price was $0.18, while it touched its highest price for the day at $0.20. BCLI beta value stands at 0.49 points. BrainStorm Cell Therapeutics Inc. is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD) and Spinal Cord Injury.
Why Should Investors Buy BCLI After the Recent Fall?Just Go Here and Find Out
Kubota Corp (ADR) (OTCMKTS:KUBTY) reported the drop of -0.30%, to close at $72.87, with the overall traded volume of 202,124.00 shares.
So far, in the past three months, the stock is down -16.03%. The 52-week range for the stock is $46.78 and $88.38 and during the previous trading session the stock touched its highest price at $73.29. Its introductory price for the day was $73.29. KUBOTA CORPORATION is a manufacturer of farm equipment, engines and construction machinery. The Company is also a producer of various pipe-related products, principally ductile iron pipes and environment-related products, such as environmental plants.
Will KUBTY Get Buyers Even After The Recent Rally? Find Out Here
About Penny Stock Divas
PSD is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our penny stock picks. We use social media tools such as Twitter and Facebook, enabling you to receive time sensitive information in a real-time manner. When you sign up for our FREE penny stock newsletter, you will receive our latest hot penny stock alerts! We have new investment ideas for penny stocks with research and commentary in the penny stock market.
PSD is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and the company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)